CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321

Agents, Embolic, For Treatment Of Uterine Fibroids

Boston Scientific Corporation

The following data is part of a premarket notification filed by Boston Scientific Corporation with the FDA for Contour Embolization Particles, Models M0017600121, M0017600221, M0017600321.

Pre-market Notification Details

Device IDK100663
510k NumberK100663
Device Name:CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321
ClassificationAgents, Embolic, For Treatment Of Uterine Fibroids
Applicant Boston Scientific Corporation ONE SCIMED PLACE Maple Grove,  MN  55311
ContactDebbie Mcintire
CorrespondentDebbie Mcintire
Boston Scientific Corporation ONE SCIMED PLACE Maple Grove,  MN  55311
Product CodeNAJ  
CFR Regulation Number870.3300 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2010-03-08
Decision Date2010-04-16
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.